Heading into 2025, the chief item on argenx’s agenda is the FDA’s April 10 target action date to decide on the approval of a ...

[32] Therefore, chronic urticaria and/or angioedema are not considered indications for SIT ... demonstrated efficacy of six weekly injections of vaccine containing CpG conjugated to the major ...

Firstly, the patient would need to have an indication to receive the medicine ... with very little skin reactions at the injection site noted in patients who received the subcutaneous version, and ...

The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...

Bristol Myers (BMY) Squibb announced that the U.S. FDA granted approval for Opdivo Qvantig injection for subcutaneous use ... solid tumor Opdivo indications as monotherapy, monotherapy maintenance ...

Bristol Myers Squibb's Opdivo has been approved in a subcutaneous injection formulation by the ... across almost all of Opdivo's lengthy list of indications in nearly a dozen different types ...

Subcutaneous immunotherapy (SCIT ... effectiveness of SCIT compared with conventional medication treatment, novel indications and formulations for SCIT are also explored in this review.